Zai Lab

Zai Lab Equity Ratio

The Equity Ratio of Zai Lab (ZLAB) as of Nov 22, 2026 is 61.03 %. In the previous year, Equity Ratio was 70.92 % — a change of -13.94% (lower).

Equity Ratio

61.03 %

YoY

-13.94%

Last updated:

Equity Ratio of Zai Lab is 2025 61.03 % . Equity Ratio of Zai Lab was 2024 70.92 % . It decreases by -13.94% lower compared to the previous year.

The Zai Lab Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
83.14 USD
Jan 1, 2019
82.97 USD
Jan 1, 2020
90.11 USD
Jan 1, 2021
85.71 USD
Jan 1, 2022
85.69 USD
Jan 1, 2023
76.82 USD
Jan 1, 2024
70.92 USD
Jan 1, 2025
61.03 USD
The Zai Lab Equity Ratio history
YEAREquity RatioYoY
61.03 %-13.94%
70.92 %-7.69%
76.82 %-10.35%
85.69 %-0.02%
85.71 %-4.88%
90.11 %+8.61%
82.97 %-0.21%
83.14 %-11.74%
94.21 %-262.47%
-57.98 %-56.00%
-131.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Equity Ratio of Zai Lab is 61.03 % in 2025.

Equity Ratio of Zai Lab changed from 70.92 % to 61.03 %, representing a -13.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Zai Lab since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Zai Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zai Lab

All Key Metrics — Zai Lab